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Generation of nitric oxide from S-nitrosothiols using 
protein-bound Cu*+ sources 
Andrew P Dicks and D Lyn H Williams 
Background: We have recently shown that S-nitrosothiols (RSNOs) 
decompose in aqueous buffer to give nitric oxide, an important signalling 
molecule, and the corresponding disulphides. This occurs by reaction with Cu+ 
generated from Cu 2c (supplied as hydrated Cu*+) by thiolate reduction. To 
establish whether these reactions are feasible in viva, we set out to determine 
whether Cu2+ bound to an amino acid, a tripeptide or to human serum albumin 
(HSA) could serve as a Cu+ source for generation of NO from S-nitrosothiols. 
Results: Experiments with Cu *+ bound to the tripeptide Gly-Gly-His or to two 
histidine molecules or to HSA showed that Cu+ was released (and trapped with 
neocuproine) when the copper source was treated with a thiol at pH 7.4. RSNO 
decomposition was achieved with all three copper sources, although not as 
rapidly as with added hydrated Cu2+. Decomposition was also catalyzed by 
ceruloplasmin. 
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Conclusions: These results show clearly that amino-acid- and protein-bound 
Cu2+ can be reduced by thiolate ion to Cu+, which will generate NO from RSNO 
species, thus providing a realistic model for these reactions in viva. 
Introduction 
Interest in the chemistry and biology of nitric oxide (NO) 
is now intense, following the series of discoveries since 
1986, indicating that it is synthesized in vivo from 
L-arginine and has a role in many physiological processes 
[l-4]. S-Nitrosothiols (RSNOs), sometimes called 
thionitrites, but henceforth referred to as nitrosothiols, are 
important as potential therapeutic drugs for the in vivo 
delivery of NO and as possible intermediates in the in 
vivo chemistry and transport of NO; S-nitrosoglutathione 
(GSNO) and other nitrosothiols have been detected in 
vivo [5]. The physical and chemical properties of 
nitrosothiols have been reported [6,7]. 
presented in favour of both views 115,161. Whatever the 
mechanism may be, there is no doubting their clinical 
efficacy; GSNO has been shown in clinical trials to be 
effective in the prevention of platelet aggregation after 
coronary angioplasty [17] and also for the treatment of a 
form of pre-eclampsia [ 181. 
Nitrosothiols decompose both thermally and photo- 
chemically initially according to equation (l), although 
NO will react further in the presence of oxygen. 
Aorhv 
ZRSNO - RSSR + 2NO (1) 
Glyceryl trinitrate (GTN) is by far the most successful and The photochemical decomposition of GSNO, when 
widely used NO-releasing drug, and a mechanism for the irradiated at 340 nm or 545 nm, has been recently 
reaction has been proposed [8]. GTN has been used described [19]. There are also many reports in the liter- 
clinically for over 100 years for the treatment of angina ature of the decomposition of nitrosothiols in solution, 
and problems of the blood circulation system. It suffers, typically at pH 7.4, when the initial products are the same 
however, from certain drawbacks - it is rather short as in equation (l), but in the presence of oxygen the NO is 
acting and some patients soon develop a tolerance to it [9]. converted quantitatively to NO,-. We have recently 
Thus, there has been much effort directed at the design of established the main mechanistic features of the 
alternative NO-releasing drugs, and nitrosothiols are decomposition of nitrosothiols in aqueous buffers. 
attractive possibilities, since it is known that they liberate Reaction is brought about by Cu”+ but not significantly by 
NO in solution. The biological properties of nitrosothiols any other metal ions [ZO]. Even at very low concentrations, 
are akin to those of NO itself; they induce vasodilation where Cu2+ is present as an impurity in the water or buffer 
[lo-121 and prevent platelet aggregation [13,14]. There is (typically 1 x 10m6 M), reaction can occur. The rate of 
some debate as to whether the action of nitrosothiols reaction is clearly dependent on the concentration of Cuz+; 
depends on their ability to release NO, or whether they it is thus not surprising that a range of rate constants has 
act without such prior decomposition. Evidence has been been reported in the literature, given the likely spread of 
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Figure 1 
+I 
Structure of the Cu+ complex with neocuproine. 
adventitious Cu2+-concentration values. No reaction occurs 
when Cuz+ is removed from solution with EDTA, even for 
the most reactive compounds (e.g., S-nitrosocysteine). 
More recently, it has become clear that the true reagent in 
these reactions is in fact Cu+, generated by reduction of 
Cuz+ by thiolate ion [‘Zl] (eq. Z), which is a well known 
reaction [Z&23]. Thiolate ion could be present in these 
solutions as a derivative of any thiol impurities in RSNO 
samples (given that they are synthesized by nitrosation of 
thiols [7]) or by hydrolysis of nitrosothiols (eq. 3), a 
reaction that has been demonstrated independently of the 
metal reduction reaction. 
Cd’ + RS- = Cu+ + RS’ (2) 
RSNO + ZOH- = RS- + NO,- + H,O (3) 
Mayer and colleagues [24] have also recently shown that 
GSNO decomposition is brought about by Cu+. Rates of 
reaction are of course dependent on the concentration 
RS- (as well as on Cu2+ concentration), which explains 
further why values reported in the literature, obtained 
before this mechanistic interpretation was presented, are 
so variable and are generally worthless. There is a large 
structure-reactivity dependence, and analysis of the 
results shows that the greatest reactivity occurs when Cu+ 
can coordinate bidentately with two nucleophilic sites 
within the nitrosothiol. 
All of these results were obtained with hydrated Cu2+ ion 
as the source of copper; this ion may be present as an 
impurity or added as a Cu(I1) salt. Although there is 
almost 0.1 g of copper per 75 kg human body weight, very 
little of it is present as hydrated Cuz+. If we are to 
consider this copper-mediated reaction as a potential 
source of NO in viva, it is clearly important to establish 
whether protein-bound sources of Cuz+, such as those 
present in the body, can release Cu+ and thus effect the 
decomposition of nitrosothiols. 
Results 
We chose to examine the possible reactions of S-nitroso- 
thiols with Cuz+ bound to three different molecules: to 
two molecules of histidine (ZHIS-Cu2+), to the tripeptide 
Gly-Gly-His (GGH-Cu2+) or to human serum albumin 
(HSA), bound as the mono-(HSA-Cu2+) complex. It has 
been argued [ZS] that GGH-Cu2+ is a good model for in 
viva binding of copper, which has an association constant 
of 8 x 1015 dm3 mol-l. Initially we chose to work with 
S-nitrosocysteine (SNC), because of the importance of 
cysteine in viva. SNC is not stable in its pure form, but 
solutions can readily be prepared by mixing equimolar 
amounts of cysteine and sodium nitrite in mildly acidic 
aqueous solutions. Such stock solutions (at -1 x 10m2 M) 
were sufficiently stable to use, and fresh stock solutions 
were prepared for each group of experiments. We also 
carried out similar experiments with two other S-nitroso- 
thiols, to establish the generality of copper-mediated 
decomposition for the production of nitric oxide. 
We first established whether thiolate ion would reduce 
these bound forms of Cu2+ to Cu+. This seemed to be the 
case qualitatively, since the addition of an equimolar 
amount of cysteine to a solution of GGH-CL?+ (2 x 10” M) 
at pH 7.4 caused an immediate and substantial reduction 
Figure 2 
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Treatment of GGH-CL?+ with the thiol N-acetyl penicillamine results in 
release of Cu+. The reaction is carried out in the presence of the Cu+ 
chelator neocuproine, and generation of Cu+ is detected by an 
increase in the absorbance at 453 nm, which is characteristic of the 
CL? chelate of neocuproine. 
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SNC decomposes in the presence of GGH-CL?+ with a first-order rate 
constant. In the presence of excess neocuproine the reaction is 
inhibited due to chelation of free Cu+. 
of the absorbance at 527 nm, which is due to the Cu2+ 
complex (data not shown). When GGH-Cu2+ (‘2 x lo-“ M) 
was treated with an equivalent amount of a thiol in the 
preserme of the specific Cu+ chelator neocuproine 
(4 x lOA M) [26], there was a quantitative and rapid build 
up of an absorbance at 4.53 nm which is characteristic of 
the Cu+-chelate with the structure shown in Figure 1. 
The increasing absorbance for scans taken every minute 
is plotted in Figure 2, which shows the generation of the 
Cu+ complex from the reduction of GGH-Cu2+ by the 
thiol i\i-acetyl penicillamine. A very similar plot was 
obtained when cysteine was used as the reducing thiol. 
The same behaviour was also observed when HSA-Cu2+ 
was treated with either of these thiols. We obtained 
significant yields of the Cu+ chelate (68 % of the 
theoretical maximum from GGH-Cu2+, 52 % from ZHIS- 
Cu2+ and 40 % from HSA-CuZ+) for all three sources of 
bound Cu2+. The yields are based on the known 
extinction coefficient of the Cu+-neocuproine complex at 
453 nm; treatment of free hydrated Cu2+ with reducing 
thiols resulted in 80 % reduction to Cu+. 
Decomposition of SNC occurred in the presence of these 
Cu2+ complexes. Addition of increasing amounts of 
neocuproine, however, progressively decreased the rate 
constant for the reaction, and decomposition was virtually 
halted at high neocuproine concentration (see Fig. 3). 
Exactly the same behaviour has been reported by us [Zl] 
and others [24] for the reactions in the presence of 
hydrated Cu2+. 
To compare the reactivities of the various complexes to 
that of hydrated Cuz+, we have examined the rate of 
decomposition of RSNO in the presence of each species 
(Fig. 4). The bound forms of Cuz+ clearly bring about 
decomposition of nitrosothiols, but not as effectively as 
does the free hydrated Cuz+ ion itself. We obtained first- 
order rate constants in all cases as a function of the 
concentration of added copper complex. Figure 5 shows 
the relevant data for the decomposition reaction of SNC 
in the presence of added Cu2+, which establish that the 
rate is described by equation 4. The measured first-order 
rate constant k, is given by equation 5 in which k1 (the 
intercept of plots of k, vs copper-complex concentration) 
represents the reaction due to free hydrated Cuz+, 
adventitiously present in the water/buffer components. 
Rate = k [copper complex] [RSNO] + k1 [RSNO] (4) 
k0 = k [copper complex] + k1 (5) 
Similar plots were obtained for reactions in the presence of 
ZHIS-CuZ+,GGH-CL?+ and HSA-CuZ+. The slope of the 
line gives the value of k, and those values for the reactions 
with all the sources of Cu2+ studied are shown in Table 1. 
Similar results were obtained with two other nitrosothiols, 
S-nitroso-N-acetyl penicillamine (SNAP) and S-nitroso(Z- 
mercaptopropionyl)glycine; it is thus likely that these 
reactions are general for all S-nitrosothiols. 
We examined whether the glyoprotein ceruloplasmin 
could serve as a copper source for the decomposition of 
S-nitrosothiols, since most of the total copper in blood 
plasma is complexed to this protein. Over the concen- 
tration range of l-5 x 1O-6 M ceruloplasmin, we found 
a linear dependence of the rate constant for SNC 
decomposition on the ceruloplasmin concentration (data 
not shown). 
Figure 4 
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Different copper sources catalyze the decomposition of SNAP at 
different rates. (a) Cu*+ (1 x 1 Oe5 M), (b) GGH-Cu2+ (1 x 1 Om5 M), (c) 
HSA-Cu2+ (1 x 1 O-5 M), (d) HSA (1 x 1 O-5 M). 
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Figure 5 
0 0.2 0.L 0.6 0.8 1.0 1.2 l.L 1.6 
[Cu2+] (M x 10-6) 
The decomposition reaction of SNC in the presence of added Cu2+ 
has a first-order rate constant. The values of k, are shown as a function 
of Cu*+ concentration. 
Discussion 
We have shown here that Cu+ can be generated from 
GGH-CL?+, ZHIS-Cu2+ and HSA-Cuz+ by treatment with 
a reducing thiol. The generation of Cu+ was detected by 
the disappearance of the Cu 2+ absorbance at 527 nm and 
the concurrent increase in the absorbance at 453 nm, 
when the reaction was carried out in the presence of 
neocuproine. A similar reduction of bound Cu2+ has been 
observed when ceruloplasmin [27], the blue copper 
oxidase of vertebrate plasma, is treated with cysteine. All 
of the copper complexes studied catalyzed the 
decomposition of nitrosothiols, releasing nitric oxide. In 
the reaction with SNAP, the reactivity order of the copper 
sources tested was: free hydrated Cu2+> GGH-Cu2+> 
HSA-Cu2+ (Fig. 4). HSA on its own seems to inhibit the 
reaction by complexation of the very small amount of 
Cu2+ present in the system, generating a concentration of 
HSA-CuZ+ of a much lower order of magnitude than those 
used in these studies. The Cu+ chelator neocuproine 
Table 1 
Values of k (eq. 5) for the decomposition of SNC using various 
sources of Cu2+. 
Copper source k (dm3 mol-’ s-l) 
Free hydrated CU*+ 60 000 
2HISCL?+ 50 000 
GGH-CL?+ 11 600 
HSA-Cu*+ 14600 
progressively reduces the rate of SNC decomposition 
initiated by GGH-Cu2+. 
The reactivity order of the various copper sources with 
SNC was: free hydrated Cu2+> ZHIS-CuZ+> HSA-Cu2+> 
GGH-Cuz+ (Table 1). All of these reaction rates are 
crucially dependent upon the concentration of RS-, 
either present initially or generated by hydrolysis of 
RSNO. In this case all of the experiments were carried 
out using solutions of SNC prepared by nitrosation of 
cysteine. As expected, none of the bound forms of Cu2+ 
is as reactive as is the free hydrated Cuz+; nevertheless, 
all show significant reactivity. We were also able to 
detect catalysis of SNC decomposition by ceruloplasmin, 
suggesting strongly that Cu+ can be released from that 
source by thiolate reductionwhich then can bring about 
nitric oxide release by decomposition of SNC. 
Significance 
Our experiments clearly show that Cu2+ bound to an 
amino acid, peptide or protein is accessible to reduction 
to Cu+ by cysteine and other thiols in aqueous solution 
at pH 7.4. Cu+ generated in this way is able to bring 
about the decomposition of S-nitrosothiols to yield 
nitric oxide in exactly the same way as does Cu+ 
generated by reduction of free hydrated Cu2+. This 
means that we can propose a realistic pathway for the 
formation of nitric oxide in vivo from S-nitrosothiols 
using copper sources present in the body. This pathway 
could be important mechanistically in providing an 
explanation for the role of S-nitrosothiols (which many 
people believe are important in the biology of nitric 
oxide) in the possible storage and delivery of nitric 
oxide in vivo. These results also provide a mechanism 
for nitric oxide generation from S-nitrosothiols 
administered therapeutically, which may lead to the 
widespread development of S-nitrosothiols as nitric 
oxide-releasing drugs. 
Materials and methods 
All of the nitrosothiols used in this work have been previously 
described [20,21]. Histidine, GGH, HSA and neocuproine were all 
commercial samples used without further purification, and the copper 
complexes were prepared by the addition of an equivalent amount of 
Cu*+. Measurements were all made by conventional UV spectro- 
photometry and rate constants obtained by noting the disappearance 
of the absorbance due to the nitrosothiol at 340 nm and using 
conventional software packages. 
Cu+ formation 
Typical experimental conditions were [GGH-Cu*+l = [cysteinel = 
2 x 1 Om4 M, [neocuproine] = 1 x 1 Oe3 M; final absorbance at 453 nm = 
1 .lO, corresponding to a Cu+ yield of 68 %. Each measurement was 
carried out three times and the standard error was -2 %. 
Kinetic experiments 
Stock solution of SNC was prepared from cysteine and sodium nitrite 
(both at about 1 x 1 OT2 M), and aliquots were added to a phosphate 
buffer at pH 7.4, containing the copper complex. The concentration of 
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the nitrosothiol was about 1 x 1 Om3 M at the start of the reaction, which 
was followed in a conventional spectrophotometer, noting the dis- 
appearance of the absorbance at 350 nm due to the nitrosothiol. The 
results were collected and analyzed using standard kinetics software 
packages. Reactions were first order and were reproducible to within 
-3 %. Reactions with S-nitroso(2-mercaptopropionyl)glycine were 
carried out in the same way, whereas the experiments with SNAP 
involved making a standard solution of SNAP from the stable solid 1281. 
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